Affected populations: Acromegaly is estimated to affect approximately 50 to 70 people out of every million. However, the true figure may be higher, as the symptoms develop slowly and thus may go ...

The FDA declined to approve investigational octreotide (CAM2029) extended-release injection for acromegaly ... (The BMJ) In a ...

A generic version of a treatment for acromegaly is now available for adults in the U.S., according to an industry press release. Adults diagnosed with endogenous Cushing’s syndrome have a higher ...